These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20618395)

  • 1. Metabotropic glutamate receptors as a target for anticonvulsant and anxiolytic action in immature rats.
    Mares P; Mikulecká A; Tichá K; Lojková-Janecková D; Kubová H
    Epilepsia; 2010 Jul; 51 Suppl 3():24-6. PubMed ID: 20618395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-dependent anticonvulsant action of antagonists of group I glutamate metabotropic receptors in rats.
    Mares P
    Epilepsy Res; 2009 Feb; 83(2-3):215-23. PubMed ID: 19097860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonists of group I metabotropic glutamate receptors and cortical afterdischarges in immature rats.
    Lojková-Janecková D; Ng J; Mares P
    Epilepsia; 2009 Sep; 50(9):2123-9. PubMed ID: 19486355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mGluR5 and mGluR1 antagonists on anxiety-like behavior and learning in developing rats.
    Mikulecká A; Mares P
    Behav Brain Res; 2009 Dec; 204(1):133-9. PubMed ID: 19505510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticonvulsant action of an antagonist of metabotropic glutamate receptors mGluR5 MPEP in immature rats.
    Lojková D; Mares P
    Neuropharmacology; 2005; 49 Suppl 1():219-29. PubMed ID: 15950993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MPEP, an antagonist of metabotropic glutamate receptors, exhibits anticonvulsant action in immature rats without a serious impairment of motor performance.
    Mares P; Mikulecká A
    Epilepsy Res; 2004 Jun; 60(1):17-26. PubMed ID: 15279866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles.
    Varty GB; Grilli M; Forlani A; Fredduzzi S; Grzelak ME; Guthrie DH; Hodgson RA; Lu SX; Nicolussi E; Pond AJ; Parker EM; Hunter JC; Higgins GA; Reggiani A; Bertorelli R
    Psychopharmacology (Berl); 2005 Apr; 179(1):207-17. PubMed ID: 15682298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excitatory aminoacids and epileptic seizures in immature brain.
    Mares P; Folbergrová J; Kubová H
    Physiol Res; 2004; 53 Suppl 1():S115-24. PubMed ID: 15119942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral consequences of the mGlu5 receptor antagonist MTEP in immature rats.
    Tichá K; Mikulecká A; Mareš P
    Pharmacol Biochem Behav; 2011 Oct; 99(4):619-25. PubMed ID: 21703298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats.
    Pietraszek M; Sukhanov I; Maciejak P; Szyndler J; Gravius A; Wisłowska A; Płaźnik A; Bespalov AY; Danysz W
    Eur J Pharmacol; 2005 May; 514(1):25-34. PubMed ID: 15878321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide].
    Satow A; Maehara S; Ise S; Hikichi H; Fukushima M; Suzuki G; Kimura T; Tanak T; Ito S; Kawamoto H; Ohta H
    J Pharmacol Exp Ther; 2008 Aug; 326(2):577-86. PubMed ID: 18487514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors.
    Lea PM; Movsesyan VA; Faden AI
    Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety.
    Busse CS; Brodkin J; Tattersall D; Anderson JJ; Warren N; Tehrani L; Bristow LJ; Varney MA; Cosford ND
    Neuropsychopharmacology; 2004 Nov; 29(11):1971-9. PubMed ID: 15305166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of two N-methyl-D-aspartate receptor antagonists on seizures, spontaneous behavior, and motor performance in immature rats.
    Mares P; Mikulecká A
    Epilepsy Behav; 2009 Jan; 14(1):32-9. PubMed ID: 18786655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticonvulsant actions of LY 367385 ((+)-2-methyl-4-carboxyphenylglycine) and AIDA ((RS)-1-aminoindan-1,5-dicarboxylic acid).
    Chapman AG; Yip PK; Yap JS; Quinn LP; Tang E; Harris JR; Meldrum BS
    Eur J Pharmacol; 1999 Feb; 368(1):17-24. PubMed ID: 10096765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents.
    Spooren WP; Vassout A; Neijt HC; Kuhn R; Gasparini F; Roux S; Porsolt RD; Gentsch C
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1267-75. PubMed ID: 11082464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease.
    Dekundy A; Pietraszek M; Schaefer D; Cenci MA; Danysz W
    Brain Res Bull; 2006 Apr; 69(3):318-26. PubMed ID: 16564428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-dependent suppression of hippocampal epileptic afterdischarges by metabotropic glutamate receptor 5 antagonist MTEP.
    Zavala-Tecuapetla C; Kubová H; Otáhal J; Tsenov G; Mareš P
    Pharmacol Rep; 2014 Oct; 66(5):927-30. PubMed ID: 25150003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anxiolytic-like activity of AIDA (1-aminoindan-1,5-dicarboxylic acid), an mGLu 1 receptor antagonist.
    Kłodzińska A; Tatarczyńska E; Stachowicz K; Chojnacka-Wójcik E
    J Physiol Pharmacol; 2004 Mar; 55(1 Pt 1):113-26. PubMed ID: 15082872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonists of Metabotropic Glutamate Receptors Prevent the Development of Audiogenic Seizures.
    Bashkatova VG; Sudakov SK; Prast H
    Bull Exp Biol Med; 2015 May; 159(1):1-3. PubMed ID: 26033576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.